Brief: Shilpa Medicare Says USFDA Inspection At Hyderabad Facility Closed With Zero 483 Observations
25/06/2024 09:34
June 25 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* USFDA INSPECTION CLOSE OUT OF BIO-ANALYTICAL LABORATORY, UNIT 7, HYDERABAD
* USFDA INSPECTION CLOSED WITH THE ISSUANCE OF ESTABLISHMENT INSPECTION
REPORT
* FACILITY IS CLASSIFIED AS NO ACTION INDICATED
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026